AU2001237712A1 - Method for increasing the gene expression of transfected genes - Google Patents

Method for increasing the gene expression of transfected genes

Info

Publication number
AU2001237712A1
AU2001237712A1 AU2001237712A AU3771201A AU2001237712A1 AU 2001237712 A1 AU2001237712 A1 AU 2001237712A1 AU 2001237712 A AU2001237712 A AU 2001237712A AU 3771201 A AU3771201 A AU 3771201A AU 2001237712 A1 AU2001237712 A1 AU 2001237712A1
Authority
AU
Australia
Prior art keywords
increasing
gene expression
transfected genes
transfected
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237712A
Inventor
Claudio Pisano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU2001237712A1 publication Critical patent/AU2001237712A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides a method of increasing the gene expression of transfected genes which includes the administration of a carnitine.
AU2001237712A 2000-02-17 2001-02-09 Method for increasing the gene expression of transfected genes Abandoned AU2001237712A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000RM000077A IT1316990B1 (en) 2000-02-17 2000-02-17 METHOD TO INCREASE GENE EXPRESSION FOR TRANSFECTED GENES.
ITRM200A000077 2000-02-17
PCT/IT2001/000057 WO2001061025A1 (en) 2000-02-17 2001-02-09 Method for increasing the gene expression of transfected genes

Publications (1)

Publication Number Publication Date
AU2001237712A1 true AU2001237712A1 (en) 2001-08-27

Family

ID=11454443

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237712A Abandoned AU2001237712A1 (en) 2000-02-17 2001-02-09 Method for increasing the gene expression of transfected genes

Country Status (19)

Country Link
US (2) US20030022859A1 (en)
EP (1) EP1257658B1 (en)
JP (1) JP4726378B2 (en)
KR (1) KR100768264B1 (en)
AT (1) ATE366320T1 (en)
AU (1) AU2001237712A1 (en)
CA (1) CA2400110A1 (en)
CY (1) CY1106872T1 (en)
CZ (1) CZ303403B6 (en)
DE (1) DE60129206T2 (en)
DK (1) DK1257658T3 (en)
ES (1) ES2288164T3 (en)
HU (1) HUP0204460A2 (en)
IT (1) IT1316990B1 (en)
MX (1) MXPA02007959A (en)
PL (1) PL204125B1 (en)
PT (1) PT1257658E (en)
SK (1) SK287759B6 (en)
WO (1) WO2001061025A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316990B1 (en) * 2000-02-17 2003-05-26 Sigma Tau Ind Farmaceuti METHOD TO INCREASE GENE EXPRESSION FOR TRANSFECTED GENES.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000137A1 (en) * 1993-06-21 1995-01-05 Bernardini, Attilio Use of acylcarnitin to treat illnesses caused by aids
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
IT1290801B1 (en) * 1996-07-05 1998-12-11 Mendes Srl USE OF ACETYL L-CARNITINE, ISOVALERYL L-CARNITINE, PROPIONYL L-CARNITINE OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS
WO1999007094A2 (en) 1997-07-31 1999-02-11 Larkom, L.L.C. Shared high speed network access
EP0996739A2 (en) * 1998-05-06 2000-05-03 Transgene S.A. Improvments in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
IT1299172B1 (en) * 1998-05-06 2000-02-29 Sigma Tau Ind Farmaceuti PERFLUORINATED ESTERS OF ALCANOYL L-CARNITINE USABLE AS CATIONIC LIPIDS FOR THE INTRACELLULAR DELIVERY OF COMPOUNDS
WO2000001418A1 (en) * 1998-07-02 2000-01-13 Genzyme Corporation Transgene expression in polarized cells
IT1316990B1 (en) * 2000-02-17 2003-05-26 Sigma Tau Ind Farmaceuti METHOD TO INCREASE GENE EXPRESSION FOR TRANSFECTED GENES.

Also Published As

Publication number Publication date
DK1257658T3 (en) 2007-11-05
ITRM20000077A0 (en) 2000-02-17
SK11872002A3 (en) 2002-11-06
ES2288164T3 (en) 2008-01-01
EP1257658A1 (en) 2002-11-20
US7560439B2 (en) 2009-07-14
PL365011A1 (en) 2004-12-27
EP1257658B1 (en) 2007-07-04
SK287759B6 (en) 2011-09-05
CZ20022757A3 (en) 2003-02-12
CZ303403B6 (en) 2012-08-29
DE60129206T2 (en) 2008-03-06
PT1257658E (en) 2007-09-14
KR20030072204A (en) 2003-09-13
ITRM20000077A1 (en) 2001-08-17
ATE366320T1 (en) 2007-07-15
JP4726378B2 (en) 2011-07-20
DE60129206D1 (en) 2007-08-16
US20050124570A1 (en) 2005-06-09
KR100768264B1 (en) 2007-10-18
JP2003522544A (en) 2003-07-29
CA2400110A1 (en) 2001-08-23
WO2001061025A1 (en) 2001-08-23
IT1316990B1 (en) 2003-05-26
CY1106872T1 (en) 2012-09-26
MXPA02007959A (en) 2003-02-10
PL204125B1 (en) 2009-12-31
HUP0204460A2 (en) 2003-04-28
US20030022859A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
AU2001292183A1 (en) Jet, an artificial promoter for gene expression
WO2002006218A3 (en) STABILIZED 1α-HYDROXY VITAMIN D
AU2002229701A1 (en) Method for inhibiting the expression of a target gene
AU8005598A (en) New uses for compounds which reduce (c-jun) gene expression
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
AU2001278918A1 (en) Novel lipase genes
WO2002053519A3 (en) Hydrophobic polyamine analogs and methods for their use
AU2003268096A1 (en) ANTISENSE MODULATION OF Nav1.3 EXPRESSION
AU2001227903A1 (en) Everninomicin biosynthetic genes
AU2001250428A1 (en) Genes of the 1-desoxy-d-xylulose biosynthesis path
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
AU5491701A (en) Lingual arch developer
AU2002223548A1 (en) Improved method for the biosynthesis of vitamin e
AU2002346805A1 (en) Genes from the corynebacterium glutamicum coding for regulatory proteins
AU6279500A (en) Epothilone compositions
AU2001237712A1 (en) Method for increasing the gene expression of transfected genes
AU2001266740A1 (en) Promoters for regulated gene expression
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2003259185A1 (en) Process for regulating gene expression
AU2002362800A1 (en) Modulation of the expression of genes dependent on stat-1
AU2002325305A1 (en) Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
AU2002245166A1 (en) Regulators of fungal gene expression
AU2002219992A1 (en) Targeted regulation of gene expression
TWI328610B (en) Biosynthetic genes for butenyl-spinosyn insecticide production
WO2003106415A3 (en) Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid